FOXO1 and disease of the tendon: First, we did not use apoptosis inhibitors, autophagy inhibitors, antioxidants, or FOXO1 signaling inhibitors in vivo to further detect whether apoptosis, autophagy, ROS, or FOXO1 signaling might be involved in the pathogenesis of tendinopathy in hypercholesterolemia.